https://orcid.org/0000-0002-8382-0789
Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Ramona Gaa, Hannah Melina Mayer, Daniela Noack, Kavita Kumari, Ralf Guenther, Shang-Pu Tsai, Qingyong Ji & Achim Doerner. (2023) Mammalian display to secretion switchable libraries for antibody preselection and high throughput functional screening. mAbs 15:1.
Read now
Read now
Yang Zhang. (2023) Evolution of phage display libraries for therapeutic antibody discovery. mAbs 15:1.
Read now
Read now
Ana Antunes, Luis Alvarez-Vallina, Federico Bertoglio, Nicolas Bouquin, Stéphanie Cornen, Francis Duffieux, Pierre Ferré, Raphaëlle Gillet, Christian Jorgensen, Mark B Leick, Bernard Maillère, Hélène Negre, Mireia Pelegrin, Nicolas Poirier, Dietmar Reusch, Bruno Robert, Guy Serre, Alain Vicari, Martin Villalba, Christoph Volpers, Gavin Vuddamalay, Hervé Watier, Thierry Wurch, Lennart Zabeau, Stefan Zielonka, Baolin Zhang, Alain Beck & Pierre Martineau. (2023) 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies. mAbs 15:1.
Read now
Read now
Tushar Jain, Todd Boland & Maximiliano Vásquez. (2023) Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches. mAbs 15:1.
Read now
Read now
Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty & Andreas H. Laustsen. (2023) Assessing developability early in the discovery process for novel biologics. mAbs 15:1.
Read now
Read now
Hristo L. Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier & Pietro Sormanni. (2023) Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15:1.
Read now
Read now
Emily K. Makowski, Hongwei Chen, Matthew Lambert, Eric M. Bennett, Nicole S. Eschmann, Yulei Zhang, Jennifer M. Zupancic, Alec A. Desai, Matthew D. Smith, Wenjia Lou, Amendra Fernando, Timothy Tully, Christopher J. Gallo, Laura Lin & Peter M. Tessier. (2022) Reduction of therapeutic antibody self-association using yeast-display selections and machine learning. mAbs 14:1.
Read now
Read now
Line Ledsgaard, Andreas H. Laustsen, Urska Pus, Jack Wade, Pedro Villar, Kim Boddum, Peter Slavny, Edward W. Masters, Ana S. Arias, Saioa Oscoz, Daniel T. Griffiths, Alice M. Luther, Majken Lindholm, Rachael A. Leah, Marie Sofie Møller, Hanif Ali, John McCafferty, Bruno Lomonte, José M. Gutiérrez & Aneesh Karatt-Vellatt. (2022) In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom. mAbs 14:1.
Read now
Read now
Rahul Khetan, Robin Curtis, Charlotte M. Deane, Johannes Thorling Hadsund, Uddipan Kar, Konrad Krawczyk, Daisuke Kuroda, Sarah A. Robinson, Pietro Sormanni, Kouhei Tsumoto, Jim Warwicker & Andrew C.R. Martin. (2022) Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics. mAbs 14:1.
Read now
Read now
Nels Thorsteinson, John R. Gunn, Kenneth Kelly, Will Long & Paul Labute. (2021) Structure-based charge calculations for predicting isoelectric point, viscosity, clearance, and profiling antibody therapeutics. mAbs 13:1.
Read now
Read now
Ramona Gaa, Emmanuel Menang-Ndi, Shruti Pratapa, Christine Nguyen, Satyendra Kumar & Achim Doerner. (2021) Versatile and rapid microfluidics-assisted antibody discovery. mAbs 13:1.
Read now
Read now
Norbert Furtmann, Marion Schneider, Nadja Spindler, Bjoern Steinmann, Ziyu Li, Ingo Focken, Joachim Meyer, Dilyana Dimova, Katja Kroll, Wulf Dirk Leuschner, Audrey Debeaumont, Magali Mathieu, Christian Lange, Werner Dittrich, Jochen Kruip, Thorsten Schmidt & Joerg Birkenfeld. (2021) An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics. mAbs 13:1.
Read now
Read now
Emily K. Makowski, Lina Wu, Alec A. Desai & Peter M. Tessier. (2021) Highly sensitive detection of antibody nonspecific interactions using flow cytometry. mAbs 13:1.
Read now
Read now
Articles from other publishers (18)
Emily K. Makowski, Tiexin Wang, Jennifer M. Zupancic, Jie Huang, Lina Wu, John S. Schardt, Anne S. De Groot, Stephanie L. Elkins, William D. Martin & Peter M. Tessier. (2023) Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nature Biomedical Engineering.
Crossref
Crossref
Erica R. Vander Mause, Jillian M. Baker, Kenneth A. Dietze, Sabarinath V. Radhakrishnan, Thierry IraguhaDestiny Omili, Patricia DavisSadie L. ChidesterKatarzyna ModzelewskaJens Panse, James E. MarvinMichael L. OlsonMary Steinbach, David P. Ng, Carol S. Lim, Djordje Atanackovic & Tim Luetkens. (2023) Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity. Science Translational Medicine 15:705.
Crossref
Crossref
Olli Huhtinen, Rune Salbo, Urpo Lamminmäki & Stuart Prince. (2023) Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Jian Chen, Shizhen Qiu, Wentao Li, Kun Wang, Yu Zhang, Han Yang, Baichuan Liu, Guangfei Li, Li Li, Min Chen, Junjie Lan, Jiahua Niu, Peijie He, Lei Cheng, Gaofeng Fan, Xin Liu, Xianmin Song, Chenqi Xu, Haitao Wu & Haopeng Wang. (2023) Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness. Cell Research 33:5, pages 341-354.
Crossref
Crossref
Line Ledsgaard, Jack Wade, Timothy P. Jenkins, Kim Boddum, Irina Oganesyan, Julian A. Harrison, Pedro Villar, Rachael A. Leah, Renato Zenobi, Sanne Schoffelen, Bjørn Voldborg, Anne Ljungars, John McCafferty, Bruno Lomonte, José M. Gutiérrez, Andreas H. Laustsen & Aneesh Karatt-Vellatt. (2023) Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes. Nature Communications 14:1.
Crossref
Crossref
Hannes Ausserwöger, Matthias M. Schneider, Therese W. Herling, Paolo Arosio, Gaetano Invernizzi, Tuomas P. J. Knowles & Nikolai Lorenzen. (2022) Non-specificity as the sticky problem in therapeutic antibody development. Nature Reviews Chemistry 6:12, pages 844-861.
Crossref
Crossref
Hamideh Raeisi, Masoumeh Azimirad, Ali Nabavi-Rad, Hamid Asadzadeh Aghdaei, Abbas Yadegar & Mohammad Reza Zali. (2022) Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective. Frontiers in Immunology 13.
Crossref
Crossref
Xinyang Li, Jun Hong, Xiaoyan Gao, Meiniang Wang & Naibo Yang. (2022) Development and characterization of a camelid derived antibody targeting a linear epitope in the hinge domain of human PCSK9 protein. Scientific Reports 12:1.
Crossref
Crossref
Gertrudis Rojas. (2022) Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology. Antibodies 11:3, pages 48.
Crossref
Crossref
Erica R. Vander Mause, Djordje Atanackovic, Carol S. Lim & Tim Luetkens. (2022) Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity. Trends in Biotechnology 40:7, pages 875-890.
Crossref
Crossref
Paul J. Carter & Arvind Rajpal. (2022) Designing antibodies as therapeutics. Cell 185:15, pages 2789-2805.
Crossref
Crossref
Romany J. McLure, Sheena E. Radford & David J. Brockwell. (2022) High-throughput directed evolution: a golden era for protein science. Trends in Chemistry 4:5, pages 378-391.
Crossref
Crossref
Bernhard Valldorf, Steffen C. Hinz, Giulio Russo, Lukas Pekar, Laura Mohr, Janina Klemm, Achim Doerner, Simon Krah, Michael Hust & Stefan Zielonka. (2022) Antibody display technologies: selecting the cream of the crop. Biological Chemistry 403:5-6, pages 455-477.
Crossref
Crossref
Emily K Makowski, John S Schardt & Peter M Tessier. (2022) Improving antibody drug development using bionanotechnology. Current Opinion in Biotechnology 74, pages 137-145.
Crossref
Crossref
Jiayu Lin, Jiachang Huang, Zhaoqiang Zhang, Xinyi Yu, Xuepei Cai & Chufeng Liu. (2022) Periodontal ligament cells under mechanical force regulate local immune homeostasis by modulating Th17/Treg cell differentiation. Clinical Oral Investigations 26:4, pages 3747-3764.
Crossref
Crossref
Kyrin R. Hanning, Mason Minot, Annmaree K. Warrender, William Kelton & Sai T. Reddy. (2022) Deep mutational scanning for therapeutic antibody engineering. Trends in Pharmacological Sciences 43:2, pages 123-135.
Crossref
Crossref
Andreas H. Laustsen, Victor Greiff, Aneesh Karatt-Vellatt, Serge Muyldermans & Timothy P. Jenkins. (2021) Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery. Trends in Biotechnology 39:12, pages 1263-1273.
Crossref
Crossref
M. Frank Erasmus, Sara D’Angelo, Fortunato Ferrara, Leslie Naranjo, André A. Teixeira, Rebecca Buonpane, Shaun M. Stewart, Horacio G. Nastri & Andrew R. M. Bradbury. (2021) A single donor is sufficient to produce a highly functional in vitro antibody library. Communications Biology 4:1.
Crossref
Crossref